CV events with NSAIDs: risk high in young rofecoxib users

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1210, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NSAIDs and the risk of CV events: is there a class effect?

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

NSAIDs increase CV risk in coronary artery disease

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

HDL-C predictive of CV events in statin users

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Differential Impact of NSAIDs on Rate of Adverse Events that Require Hospitalization in High-Risk and General Veteran Populations: A Retrospective Cohort Study

By Pratt Nicole  

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite

Rofecoxib better value than NSAIDs for OA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 337, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite